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Aims Long-term exposure of humans to air pollution enhances the risk of cardiovascular and respiratory diseases.
A novel Global Exposure Mortality Model (GEMM) has been derived from many cohort studies, providing much-
improved coverage of the exposure to fine particulate matter (PM2.5). We applied the GEMM to assess excess
mortality attributable to ambient air pollution on a global scale and compare to other risk factors.
....................................................................................................................................................................................................
Methods
and results
We used a data-informed atmospheric model to calculate worldwide exposure to PM2.5 and ozone pollution, which
was combined with the GEMM to estimate disease-specific excess mortality and loss of life expectancy (LLE) in
2015. Using this model, we investigated the effects of different pollution sources, distinguishing between natural
(wildfires, aeolian dust) and anthropogenic emissions, including fossil fuel use. Global excess mortality from all ambi-
ent air pollution is estimated at 8.8 (7.11–10.41) million/year, with an LLE of 2.9 (2.3–3.5) years, being a factor of
two higher than earlier estimates, and exceeding that of tobacco smoking. The global mean mortality rate of about
120 per 100 000 people/year is much exceeded in East Asia (196 per 100 000/year) and Europe (133 per 100 000/
year). Without fossil fuel emissions, the global mean life expectancy would increase by 1.1 (0.9–1.2) years and 1.7
(1.4–2.0) years by removing all potentially controllable anthropogenic emissions. Because aeolian dust and wildfire
emission control is impracticable, significant LLE is unavoidable.
....................................................................................................................................................................................................
Conclusion Ambient air pollution is one of the main global health risks, causing significant excess mortality and LLE, especially
through cardiovascular diseases. It causes an LLE that rivals that of tobacco smoking. The global mean LLE from air
pollution strongly exceeds that by violence (all forms together), i.e. by an order of magnitude (LLE being 2.9 and
0.3 years, respectively).
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1. Introduction
Global Burden of Disease (GBD) studies have assessed major health
impacts and excess mortality rates from ambient (outdoor) air pollution,
building on a growing database from epidemiological cohort studies.1–3
The World Health Organization (WHO) indicates that more than 70%
of global mortality rates are due to non-communicable diseases
(NCD).4 We investigated to what degree the long-term exposure to air
pollution contributes to mortality by NCD, including cardiovascular and
respiratory disease, lung cancer (LC), and lower respiratory tract infec-
tions (LRI). Main health risk factors include tobacco smoking, unhealthy
diets and being overweight, hypertension, diabetes, high cholesterol, and
air pollution.2,5 The mortality attributable to air pollution can be esti-
mated with disease-specific hazard models, linked to information about
exposure to ambient concentrations.3,6 We used a global atmospheric
chemistry model to estimate exposure to ozone (O3) and fine particu-
late matter (PM2.5, particles with a diameter of less than 2.5mm),
7,8 com-
bined with the new Global Exposure Mortality Model (GEMM) of
Burnett et al.6
Compared with foregoing GBD assessments, the GEMM provides haz-
ard functions based on a larger dataset derived from 41 cohort studies in
16 countries.6 The expanded data volume and geographical coverage re-
duce uncertainty, especially for high PM2.5 concentrations, which were
previously not explicitly related to observed atmospheric conditions but
adopted from studies of second-hand smoking.9 We used the GEMM for
the following disease categories: LRI, chronic obstructive pulmonary dis-
ease (COPD), LC, ischaemic heart disease (IHD), cerebrovascular disease
(CEV) leading to stroke, i.e. similarly addressed in GBD assessments, and a
new one referred to as ‘other NCD’.10 The GBD has categorized global
exposure risks and attributable mortality rates,2,3 but such comparisons
can be ambiguous as the loss of life years differs among health risk factors
and between various regions. Here, we derive global, regional, and na-
tional attributable mortality rates, along with the years of life lost (YLL)
and the loss of life expectancy (LLE). By comparing the LLE from different
causes, we assess the health burden from air pollution relative to other
risk factors.
2. Methods
The global exposure to the air pollutants PM2.5 and O3 for the year 2015
has been computed through data-informed modelling. We used the
EMAC atmospheric chemistry—general circulation model, which was
built from a climate model11 extended with multi-phase atmospheric
chemistry submodels to account for the atmospheric processing of pol-
lution emissions.7,12,13 We distinguish fossil fuel-related, all anthropo-
genic and natural emissions, the latter mostly aeolian dust.14 While we
applied the same model calculations of air pollution exposure, as well as
baseline mortality and population data of the WHO for the year 2015
that we used previously,4,7,8 we revised the results by using the GEMM
for the effects of PM2.5.
6,10,15 This model yields age-dependent excess
mortality rates and YLL from five disease categories (LRI, COPD, IHD,
CEV, and LC), also distinguished by the GBD,2,3 plus one that describes
NCD þ LRI, from which we derive the ‘other NCD’ by subtraction.10
The burden of disease from O3 has been calculated with the hazard func-
tion of Jerrett et al.16 Uncertainty ranges are expressed as the 95% confi-
dence intervals (95% CIs), adopted from Burnett et al.6 Since the
contribution by ‘other NCD’ has been derived from the difference be-
tween the total and the known NCD, the 95% CI is relatively large (glob-
ally about ±55%) by propagating uncertainties for the five defined
disease categories, for which the 95% CI is about 20–40%. The overall
uncertainty estimate, including hazard ratio functions (GEMM) and atmo-
spheric model calculations of annual average exposure, is about ±50% of
the calculated mean values.8,10,17 For more information about the meth-
ods used, including data sources and country-level results, we refer to
the Supplementary material online. Uncertainties and limitations are dis-
cussed in greater detail in Section 4.
3. Results
3.1 Mortality estimates
Table 1 and Figure 1 present our estimates of excess mortality rates, YLL
and LLE attributable to air pollution for different regions and disease
Graphical Abstract
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categories. The global mortality rate of 8.8 (95% CI 7.11–10.41) million/
year is in good agreement with Burnett et al.6 who reported 8.9 (95% CI
7.5–10.3) million per year, and it is about a factor of two higher than in
previous studies using relative risk or hazard ratio values based on less
comprehensive epidemiological data.3,8,9 For comparison, the WHO
estimates the global mortality from tobacco smoking (active and passive)
at about 7.2 million per year.4 Geographically, the mortality from air pol-
lution is dominated by East Asia (35%) and South Asia (32%), followed
by Africa (11%) and Europe (9%). The corresponding fractions for the
YLL are 29%, 36%, 17%, and 6%, respectively. The global mean mortality
rate of 120 (97–142) per 100 000 people/year is exceeded in East Asia
[196 (160–229) per 100 000/year] and Europe [133 (108–157) per
100 000/year]. The LLE is 3.9 (3.2–4.6) years in East Asia, associated with
the large population fraction that is exposed to poor air quality.
Compared with Europe, the attributable mortality rate in South Asia is
12% lower but the LLE is 50% higher [3.3 (2.6–3.9) years], which is re-
lated to less advanced health care and child mortality. Lowest mortality
rates and LLE are found in Australia, associated with the strictest air qual-
ity standards worldwide.18
3.2 Age dependency
Figure 2 illustrates the age dependency of excess mortality, i.e. the rela-
tive distribution in 5-year intervals (and accumulated over a longer pe-
riod of above 80 years). The proportion of excess deaths generally
increases with age, but child mortality (<5 years) can be high in low-
income countries, mostly in Africa and South Asia, and related to LRI.
Figure 3 presents the relative contributions of disease categories to LLE.
It demonstrates that cardiovascular diseases (CVDs) (CEV þ IHD) plus
the other NCD dominate excess mortality. While LRI contribute 13.8%
to excess mortality globally, they make up 21.4% of LLE, influenced by
childhood mortality. The relatively high incidence of CVD outcomes is
consistent with recent analyses and partly related to previously unac-
counted, indirect cardiovascular risks.19–22 For example, PM2.5-induced
inflammation, oxidative stress, and vascular (endothelial) dysfunction
probably contribute to the development of hypertension, diabetes, and
atherosclerosis.23 It is likely that a large percentage of the other NCD
..................................................................................
..............................................................................................................................................................................................................................
Table 1 Excess mortality attributable to ambient air pollutiona
Mortality
(3103/year)
Deaths per
100000
(year21)
YLL
(3106/year)
LLE
(years)
Avoidable
LLE (years)
Avoidable
mortality
(3103/year)
Mortality for disease categories (3103/year)
LRI COPD LC CEV IHD Other
NCD
Africa 957 81 40.0 3.1 0.7 230 378 28 7 113 224 207
East Asia 3112 196 67.4 3.9 3.0 2403 204 405 300 738 779 686
South Asia 2809 119 83.6 3.3 1.9 1660 478 377 61 383 981 529
West Asia 544 94 14.6 2.3 1.0 241 50 20 19 76 292 87
Europe 790 133 14.3 2.2 1.7 608 54 38 54 64 313 267
Australia 14 47 0.3 0.8 0.2 3 0.6 0.8 0.9 0.6 4 7
North America 360 74 7.5 1.4 1.1 294 24 26 24 14 112 160
South America 207 42 5.3 1.0 0.5 115 30 9 6 14 63 85
World 8793 120 233 2.9 1.7 5554 1218 904 472 1403 2768 2028
Avoidable LLE and mortality were calculated by removing anthropogenic emissions in the model. Australia also includes other islands of Oceania. Data for all countries, including
95% uncertainty intervals, are given in the Supplementary material online, Tables (overall uncertainty about ±50%).
CEV, cerebrovascular disease; COPD, chronic obstructive pulmonary disease; IHD, ischaemic heart disease; LC, lung cancer; LLE, loss of life expectancy; LRI, lower respiratory
infections; NCD, non-communicable diseases; YLL, years of life lost.
aExcess mortality expresses the number of deaths over a given period that would not occur in the absence of exposure.
Figure 2 Age distribution of excess mortality from ambient air pollu-
tion. Globally, about 25% of the attributable mortality occurs at an age
of <60 years: in Europe about 11% and in Africa about 55%.
YLL (1000 km2)
< 0.1
10
1000
> 100000
Figure 1 Annual years of life lost from air pollution (units per
1000 km2). The global total is 233 (221–250) million per year.
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contribute to CVD mortality, typically at an advanced age. Globally,
NCD are the major cause of death, associated with hypertension, to-
bacco smoking, diabetes, and high cholesterol—and air pollution is like-
wise a leading risk factor.3,5
3.3 Comparing health risks
Figure 4 compares the LLE from different risk factors. Humans typically
fear violence most, but rational evaluation shows that, only in excep-
tional cases (Syria, Afghanistan, Honduras, Colombia, and Venezuela),
the associated mean LLE exceeds that from ambient air pollution. The
leading air pollution source sector is fossil fuel use, which includes emis-
sions from power generation, industry, traffic, and residential energy use.
The residential source additionally involves biofuel use, which relatedly
causes household air pollution (Figure 4). In India, for example, residential
biofuel use is a main factor in both ambient and household air pollu-
tion.24 In China, on the other hand, a large part of the residential air pol-
lution is from small-scale coal (hence fossil fuel) combustion.25,26 Since
residential ambient and household pollution are not independent, the as-
sociated mortality is not additive.5,27 Relatively high red colour intensities
in the upper left panel of Figure 4, compared to the other panels, shows
in which areas the LLE from ambient air pollution exceeds that from to-
bacco smoking, mostly in low- and middle-income countries. While the
prevalence of smoking decreased in the past decades, the total number
of smokers increased due to population growth.28 In the same period,
exposure to air pollution grew due to increasing population and emis-
sions in low- and middle-income countries,29 as well as ageing and
changes in non-communicable disease rates. The geographic distribution
of risk factors is quite diverse, while many come together in Africa
(Figure 4). The global mean life expectancy increased from 52 years in
1960 to 72 years in 2015 (and 80 years in high-income countries), but in
many low-income countries, including sub-Saharan Africa, it is still below
60 years, which is unsurprising in view of the multiple health risks.30,31
We note that our LLE estimates for low-income regions are possibly
lower limits, because air pollution-induced infant mortality may be higher
than assumed.32
3.4 Avoidable mortality
Finally, we calculated to what extent LLE from ambient air pollution
could be reduced by removing the avoidable anthropogenic emissions in
our atmospheric model. We find that the global LLE of 2.9 (2.3–3.5)
years (Table 1) could be reduced by 1.7 (1.4–2.0) years through the re-
moval of all potentially preventable anthropogenic emissions and by 1.1
(0.9–1.2) years through the removal of fossil fuel-related emissions
alone. This corroborates that fossil fuel-generated air pollution qualifies
as a major global health risk factor by itself. We reiterate that non-
preventable pollution sources should be distinguished in view of policy
making, mostly aeolian dust and natural wildfires, the latter being about
10% of global biomass burning. Because of the large geographic diversity
in emissions, our results indicate major regional differences. In East Asia,
3.0 (2.5–3.5) of the 3.9 (3.2–4.6) years LLE could potentially be pre-
vented, whereas in Africa, where population growth is rapid and aeolian
dust predominates, it is merely 0.7 (0.5–0.9) of 3.1 (2.3–3.8) years.
Contrasts can thus be very large. In the USA and China, up to 80–85% of
the LLE is preventable through the control of anthropogenic emissions,
whereas in Nigeria and Egypt, it is 16–17%. It should be emphasized that
additional LLE can be avoided, both generally and specifically from air
pollution, by improving health care.
4. Discussion
4.1 Major health risk
While in some parts of the world air quality remains to be poor, notably
in low- and middle-income countries, in other regions, such as North
America, Europe, and most recently China, pollution emissions have de-
creased. Then, why do attributable mortality rates continue to be so
high, and why has air pollution advanced into one of the major public
health risk factors worldwide? The answer is fourfold. First, the GEMM
accounts for other NCD that were not considered in previous analyses,
in line with growing evidence that air pollution aggravates NCD risks
such as diabetes and hypertension. Second, there is increasing support
for larger than previously assumed health impacts at very low and very
high PM2.5 concentrations, which are better represented by the GEMM
than hazard functions of former GBD assessments.6,33 Third, in many
low- and middle-income countries, population numbers and industrial
and traffic-related pollution levels continue to grow. Fourth, NCD, in
particular CVD, have become a major cause of death, accompanying the
overall increasing life expectancy. Air pollution particularly aggravates
chronic health risks, and the extended exposure takes its toll later in life.
However, while the rate of attributable NCD mortality increases, the as-
sociated LLE typically changes less due to improvements in health care.
Therefore, mortality estimates should be interpreted with caution and
complemented by YLL and LLE estimates.
4.2 Mortality metrics
The GEMM can be used to estimate how many deaths could be
avoided per year if the population were exposed to a lower counter-
factual level than current, ambient concentrations of air pollution.
Since separate risk functions are derived for age categories, the
GEMM additionally incorporates the age structure of the population.
When mortality is attributed to a risk factor such as air pollution, the
relationship is statistical but not distinctive (unlike car accidents where
Figure 3 Percentage of global life expectancy loss from air pollution
by different disease categories. CEV, cerebrovascular disease; COPD,
chronic obstructive pulmonary disease; IHD, ischaemic heart disease;
LC, lung cancer; LRI, lower respiratory infections; NCD, non-communi-
cable diseases.
4 J. Lelieveld et al.
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.excess mortality relates to persons who can be identified). To do jus-
tice to these differences, we provide several complementary metrics,
i.e. excess mortality, YLL, and LLE. While excess mortality (sometimes
indicated as premature mortality) is often used as a comparative
measure to quantify health risks, the regional diversity among total
and per capita mortality, LLE and YLL (Table 1), influenced by the
prevalence of other risk factors and health care, shows that there is
no single best metric. One could argue, for example that, for smoking
Figure 4 Mean global and country-level loss of life expectancy from different causes of death referring to the year 2015. Household air pollution is from
the indoor use of solid biofuels. Ambient residential air pollution is mostly from household sources and can include fossil and biofuel use. Parasitic and vec-
tor-borne diseases include malaria, leishmaniasis, rabies, dengue, yellow fever, and others. Violence includes interpersonal, collective conflict, and armed
intervention.
The cardiovascular risk factor air pollution 5
D
ow
nloaded from
 https://academ
ic.oup.com
/cardiovascres/advance-article-abstract/doi/10.1093/cvr/cvaa025/5770885 by guest on 11 M
arch 2020
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
.
the excess mortality (individual exposure) and for air pollution, the
LLE (population exposure) is more suitable.
4.3 Limitations and uncertainties
We emphasize that the methodology used with the GEMM is the same
as for the health effects of active smoking, obesity, and so on. Hence,
whatever limitations are relevant for outdoor air pollution, they also ap-
ply to other risk factors like smoking. Although clinical and public health
research has uncovered unambiguous associations between air pollu-
tion, disease, and mortality, even at very low levels of exposure,5,33 con-
tinued studies are needed to disentangle the physiological mechanisms,
causes, and effects. For example, the harmfulness of different types of
particles, individually and in mixtures, is not well understood.34,35 The
GEMM assumes that PM2.5 toxicity does not significantly depend on the
sources and chemical composition, which is a simplification that requires
further investigation. While previous studies of exposure–response for-
mulations assumed counterfactual (i.e. potential outcome) uncertainty
distributions, in the GEMM, this dependency has diminished by directly
deriving the shape of the exposure–mortality association from very low
to high levels of air pollution, being accounted for in several of the 41 co-
hort studies analysed by Burnett et al.6
Our calculations of mortality from air pollution include 95% CI esti-
mates, which represent uncertainty related to the data used in the calcu-
lations. The Supplementary material online, Excel Tables present excess
mortality, YLL, and LLE for all countries, for different disease categories,
and their 95% CI’s are given by the mean, minimum, and maximum val-
ues. We reiterate that the 95% CI refers to uncertainty in the parame-
ters used in the attribution calculations. There can be additional
uncertainty from incomplete knowledge, i.e. epistemic uncertainty. This
includes model assumptions for counterfactuals, unaccounted confound-
ing factors, misclassification of health, and other data, or limited repre-
sentativeness of hazard functions as they rely on data from a relatively
small number of countries (16 countries). Confounder uncertainty can
be associated with over- as well as underestimates, either by over-
attributing air pollution deaths to disease categories, as well as neglect of
air pollution impacts on diseases that are not, but should be accounted
for. For example, it is conceivable that air pollution worsens smoking-
related health effects. It should be noted that the excess mortality esti-
mated for the disease category ‘other NCD’ (Table 1, Figure 3) is associ-
ated with larger uncertainty than LRI, COPD, LC, CEV, and IHD, as the
number of deaths is not necessarily additive due to competing health
risks. The NCD þ LRI group represents the total impact of PM2.5 on
mortality and LLE. Specific causes of death are reported separately to in-
dicate their contributions to the total. Ideally, an additional GEMM
should be developed with a competing R(z) mode.
4.4 Differential toxicity of particles
Generally, the exposure calculations contribute relatively little to uncer-
tainty, being dominated by the attribution calculations. However, this
may not hold if PM2.5 toxicity significantly depends on source categories
and chemical composition, implying that exposure would be less well
characterized than assumed. While epidemiological studies have not
identified source categories that distinctively affect the health impacts of
fine particulates,3,5 toxicological investigations have reported that ex-
haust particles from diesel engines are relatively more toxic than from
gasoline engines, followed by biomass burning, coal combustion, and
road dust particles, all being significantly more hazardous than ammo-
nium sulphate and nitrate—and also suggesting that different PM2.5
mixtures influence different diseases.36 For example, we have estimated
that globally about 5% of mortality is attributable to biomass burning,7
which amounts to about 440 000 excess deaths per year. However, it is
conceivable that organic particles are significantly more toxic than inor-
ganic ones7; if this was true, the global excess mortality from biomass
burning smoke may add up to about 630 000 per year. Although it is
unclear to what extent the toxicological studies are representative for
morbidity and mortality in human populations, especially for long-term
exposure,36 it cannot be excluded that various particle sources have dif-
ferent impacts. Furthermore, there is discussion about harmfulness re-
lated to particle size. Fine particulates, PM2.5, are believed to be a more
important health concern than course particles up to 10mm in diameter
(PM10), as the smaller ones penetrate more deeply into the lungs with a
low probability to be exhaled.
Experimental studies have corroborated that PM2.5 provides a good
approximation for the extended exposure of the human respiratory
tract to particulate pollution.37 However, there remains concern that
ultrafine particles with a diameter of smaller than 0.1mm (PM0.1) could
be particularly harmful, as they can directly pass into the bloodstream
and affect other organs.38 It has been observed that specifically the small-
est fraction of PM0.1, with a diameter of below about 30 nm, can directly
translocate into the circulatory system and accumulate at sites of vascu-
lar inflammation.39 Nevertheless, two meta-studies on the health effects
of ultrafine particles concluded that the available evidence does not indi-
cate that PM0.1 is relatively more hazardous, or at least that there is no
conclusive support for it but do emphasize the need for continued stud-
ies, in particular of the long-term health effects.37,40 In view of this, espe-
cially regarding differential toxicity in terms of particle composition and
size, it seems probable that the overall uncertainty of our mortality and
life expectancy calculations is larger than the 95% CI; we estimate it at
approximately ±50%.8,10
5. Conclusion
Our comparison of different global risk factors shows that ambient air
pollution is a leading cause of excess mortality and LLE, in particular
through CVDs. Globally, the LLE from air pollution surpasses that of
HIV/AIDS, parasitic, vector-borne, and other infectious diseases by a
large margin. It exceeds the LLE due to all forms of violence by an order
of magnitude and that of smoking by a third. Nonetheless, one could ar-
gue that tobacco smoking can be entirely avoided. The removal of an-
thropogenic air pollution emissions can merely avoid about 25–80% of
LLE, i.e. within a large range, depending on the local role of natural
emissions (e.g. aeolian dust), but with substantial potential for mortality
reduction through the improvement of health care, especially in low-
income counties. The fraction of avoidable LLE from anthropogenic air
pollution that can be attributed to fossil fuel use is nearly two-thirds
globally, and up to about 80% in high-income countries.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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